MONJUVI
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 16 Jul 2026)
What this means for you
Registered since 13 Oct 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2030: the §8 & §9 renewal).
Record
- Serial number
- 88682860
- Registration number
- 6173000
- Mark type
- Design + words
- Filed
- 06 Nov 2019
- Published for opposition
- 28 Jul 2020
- Registered
- 13 Oct 2020
- Next maintenance filing
- §8 & §9 renewal, due by 13 Oct 2030 (grace period to 13 Apr 2031)
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for human[ and veterinary] use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, [ and restenosis; vaccine preparations; vaccines;] biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, [ and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents;] biological preparations for medical [and veterinary] purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases [, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders]
- Class 042 — Scientific and technological services: [Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies]
Owner
- INCYTE HOLDINGS CORPORATION, Wilmington, DE, US
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
Prosecution history
- 31 Jul 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 31 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 31 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Jul 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Jul 2026 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jul 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Apr 2026 — TEAS SECTION 8 & 15 RECEIVED
- 13 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED